Management of chronic myeloid leukemia: Targets for molecular therapy

被引：12

作者：

Barnes, DJ ^{[1
]}

Melo, JV ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Fac Med, London W12 0NN, England

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 01期

关键词：

D O I：

10.1053/shem.2003.50002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：34 / 49

页数：16

共 91 条

[81] Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase [J].

Vigneri, P ;

Wang, JYJ .

NATURE MEDICINE, 2001, 7 (02) :228-234

[82] BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571:: a prospective study [J].

von Bubnoff, N ;

Schneller, F ;

Peschel, C ;

Duyster, J .

LANCET, 2002, 359 (9305) :487-491

[83] INCREASED NEUTROPHIL RESPIRATORY BURST IN BCR-NULL MUTANTS [J].

VONCKEN, JW ;

VANSCHAICK, H ;

KAARTINEN, V ;

DEEMER, K ;

COATES, T ;

LANDING, B ;

PATTENGALE, P ;

DORSEUIL, O ;

BOKOCH, GM ;

GROFFEN, J ;

HEISTERKAMP, N .

CELL, 1995, 80 (05) :719-728

[84] Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine [J].

Walker, EH ;

Pacold, ME ;

Perisic, O ;

Stephens, L ;

Hawkins, PT ;

Wymann, MP ;

Williams, RL .

MOLECULAR CELL, 2000, 6 (04) :909-919

[85] The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products [J].

Wen, ST ;

Jackson, PK ;

VanEtten, RA .

EMBO JOURNAL, 1996, 15 (07) :1583-1595

[86] INHIBITION OF HEAT-SHOCK PROTEIN HSP90-PP60(V-SRC) HETEROPROTEIN COMPLEX-FORMATION BY BENZOQUINONE ANSAMYCINS - ESSENTIAL ROLE FOR STRESS PROTEINS IN ONCOGENIC TRANSFORMATION [J].

WHITESELL, L ;

MIMNAUGH, EG ;

DECOSTA, B ;

MYERS, CE ;

NECKERS, LM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8324-8328

[87]

Wisniewski D, 2002, CANCER RES, V62, P4244

[88] Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes) [J].

Wu, YP ;

Yu, LJ ;

McMahon, R ;

Rossi, JJ ;

Forman, SJ ;

Snyder, DS .

HUMAN GENE THERAPY, 1999, 10 (17) :2847-2857

[89] BLOCKING OF EGF-DEPENDENT CELL-PROLIFERATION BY EGF RECEPTOR KINASE INHIBITORS [J].

YAISH, P ;

GAZIT, A ;

GILON, C ;

LEVITZKI, A .

SCIENCE, 1988, 242 (4880) :933-935

[90]

Yu CR, 2002, CANCER RES, V62, P188

← 1 2 3 4 5 6 7 8 9 10 →